Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL.

van der Moeren, N; Zwart, V F; Goderski, G; Rijkers, G T; van den Bijllaardt, W; Veenemans, J; Kluytmans, J A J W; Pas, S D; Meijer, A; Verweij, J J; Murk, J L A N; Stohr, J J J M

Publication

Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL.

van der Moeren, N; Zwart, V F; Goderski, G; Rijkers, G T; van den Bijllaardt, W; Veenemans, J; Kluytmans, J A J W; Pas, S D; Meijer, A; Verweij, J J; Murk, J L A N; Stohr, J J J M

Type

Article

Language

en

Date

2021-07-08

Show all metadata

Title

Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL.

Published in

J Clin Virol 2021; 141:104909

Abstract

The DAA had an overall specificity of 100% (95%CI 97.9%-100%) and sensitivity of 73% (95%CI 61.3%-82.7%) for the clinical samples. Sensitivity was 86% (CI95% 74.6%-93.3%) for samples with Ct-value below 30. Both the DAA and RRA detected SARS-CoV-2 up to a dilution containing 5.2 × 102 fifty-percent-tissue-culture-infective-dose (TCID50)/ml.

Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL.

Citations

Series / Report no.

Open Access

Type

Language

Date

Research Projects

Organizational Units

Journal Issue

Title

Translated Title

Published in

Abstract

Description

Publisher

Sponsors

DOI

PMID

URI

Additional Links

Embedded videos

Collections